Product Information
VENLAFAXINE HCL 100 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1169 per EA under NDC 68382010101. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Jun 13, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382010101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077653FDA Approved
6/13/2008
TE Code
AB
On Market Since
6/13/2008
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL 100 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1169 per EA |
|---|---|
| All-time high | $0.4670 (Feb 10, 2016) |
| All-time low | $0.0711 (Nov 20, 2024) |
| 52-week high | $0.1262 |
| 52-week low | $0.1051 |
| Median price | $0.1920 |
| Average price | $0.2104 |
| Largest weekly change | +56.1% (Jan 20, 2016) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL 100 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1169 per EA (NDC 68382010101), effective Aug 19, 2026.
How has the price of VENLAFAXINE HCL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL 100 MG TABLET has declined 73.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL 100 MG TABLET?
Since Nov 28, 2013, the NADAC for VENLAFAXINE HCL 100 MG TABLET has ranged from a low of $0.0711 (Nov 20, 2024) to a high of $0.4670 (Feb 10, 2016), with a median of $0.1920 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL 100 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL 100 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL 100 MG TABLET?
VENLAFAXINE HCL 100 MG TABLET (NDC 68382010101) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.